WELLS FARGO & COMPANY/MN - VIRPAX PHARMACEUTICALS INC ownership

VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 13 filers reported holding VIRPAX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of VIRPAX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$50
-25.4%
63
+1.6%
0.00%
Q2 2023$67
+42.6%
62
+3.3%
0.00%
Q1 2023$47
+27.0%
60
+1.7%
0.00%
Q4 2022$3759
+1.7%
0.00%
Q3 2022$058
+1.8%
0.00%
Q2 2022$057
+7.5%
0.00%
Q1 2022$053
+1.9%
0.00%
Q4 2021$0
-100.0%
52
-90.6%
0.00%
Q3 2021$3,000552
+4918.2%
0.00%
Q2 2021$0110.00%
Other shareholders
VIRPAX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 701,455$550,6420.48%
Quantum Private Wealth, LLC 10,000$7,8500.00%
Warberg Asset Management LLC 17,012$13,3540.00%
Belpointe Asset Management LLC 19,045$14,9500.00%
OSAIC HOLDINGS, INC. 600$4710.00%
PNC FINANCIAL SERVICES GROUP, INC. 100,875$79,1870.00%
WELLS FARGO & COMPANY/MN 60$470.00%
NORTHERN TRUST CORP 15,221$11,9480.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 66,038$51,6080.00%
View complete list of VIRPAX PHARMACEUTICALS INC shareholders